1.Sarwar Shah, SG (2020) A commentary on “World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)”. International Journal of Surgery (London, England).
2.Zhu, N et al. (2020) A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine 382, 727–733.
3.Wu, Y et al. (2020) SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet 395, 949–950.
4.Li, Q et al. (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine.
5.Zhou, P et al. (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature.
6.Chen, N et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England).
7.Xu, XW et al. (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ (Clinical Research Ed) 368, m606.
8.Wang, D et al. (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA.
9.Yang, X et al. (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine.
10.Yang, S et al. (2020) Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis. Annals of Translational Medicine 8, 128.
11.Guan, WJ et al. (2020) Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine.
12.Cao, B et al. (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. The New England Journal of Medicine.
13.Zhou, F et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England).
14.Liu, W et al. (2020) Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal.
15.Yuan, M et al. (2020) Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One 15, e0230548.
16.Huang, C et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 395, 497–506.
17.Sun, P et al. (2020) Understanding of COVID-19 based on current evidence. Journal of Medical Virology 92, 548–551.
18.Li, D et al. (2018) Evaluation of a novel prognostic score based on thrombosis and inflammation in patients with sepsis: a retrospective cohort study. Clinical Chemistry and Laboratory Medicine 56, 1182–1192.
19.JR, R et al. (2012) D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. The American Journal of Emergency Medicine 30, 1991–1999.
20.J, G et al. (2005) Multiple organ infection and the pathogenesis of SARS. The Journal of Experimental Medicine 202, 415–424.
21.H, C et al. (2016) Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. The Journal of Infectious Diseases 213, 904–914.
22.WJ, L et al. (2017) T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV. Antiviral Research 137, 82–92.